Haleon (HLN) Retained Earnings (2021 - 2025)
Haleon (HLN) posted Retained Earnings of $37.0 billion for Q4 2025, up 5.82% on a QoQ basis from $35.0 billion in Q4 2024, and up 5.82% year-over-year from $35.0 billion in Q4 2024.
Haleon (HLN) Retained Earnings (2021 - 2025) Analysis & Trends
Haleon's Retained Earnings history runs 5 years deep, the most recent figure standing at $37.0 billion for Q4 2025.
- Quarterly Retained Earnings rose 5.82% year-over-year to $37.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.0 billion (up 5.82% YoY) and the FY2025 annual result came in at $36.7 billion, up 5.32% from the prior year.
- Retained Earnings was $37.0 billion for Q4 2025 at Haleon, up from $35.0 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $37.0 billion in Q4 2025 and bottomed at -$15.7 billion in Q4 2021.
- A 5-year average of $21.6 million and a median of -$14.2 billion in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings tumbled 1282.29% — and 2024, when it jumped 341.32%.
- Haleon's Retained Earnings stood at -$15.7 billion in 2021, then soared by 107.82% to $1.2 billion in 2022, then tumbled by 1282.29% to -$14.5 billion in 2023, then soared by 341.32% to $35.0 billion in 2024, then grew by 5.82% to $37.0 billion in 2025.
- Business Quant data shows HLN's Retained Earnings at $37.0 billion in Q4 2025, $35.0 billion in Q4 2024, and -$13.9 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -319.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.04 Bn |
| Dec 31, 2024 | 35.00 Bn |
| Jun 30, 2024 | -13.91 Bn |
| Dec 31, 2023 | -14.51 Bn |
| Jun 30, 2023 | -14.45 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Jun 30, 2022 | -14.55 Bn |
| Dec 31, 2021 | -15.69 Bn |